If it's denied, your doctor has the option of appealing the decision
and providing anti-inflammatory effects
CagriSema: Awaiting a Critical FDA Decision Novo Nordisks CagriSema represents one of the most consequential pending decisions across the GLP-1 drug pipeline in 2026
If you miss a scheduled follow-up, your medication shipment can be held
Back Nathan, DM, Schreiber, E, Fogel, H, et al (Feb 1992) 'Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects', Journal Diabetes Care , 15/2, 270-6
Wegovy has a half-life of seven days, according to the drugs prescribing information, meaning that 50% of the original concentration will have been removed from the body one week after stopping it